COPD Flare-Ups and Breath Nitric Oxide Measurement
Part of Lungs & breathing clinical trials.
This study looks at how a measurement of inflammation in the breath (called fractional exhaled nitric oxide) relates to COPD flare-ups in people who are already using a triple inhaler therapy. It aims to find better ways to predict and manage COPD exacerbations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 40 years old.
- You must have a confirmed diagnosis of COPD based on a breathing test (spirometry) that shows poor lung function.
- You must have a history of smoking cigarettes.
- You must be currently using a triple inhaler (a combination of three types of medication) for your COPD, or be starting this treatment because you recently had a worsening of symptoms (exacerbation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
This study uses a special MRI scan to see how well a single triple inhaler works for people with COPD who have moderate to severe shortness of breath or feel their health is not good. It compares two groups: those with a low risk of flare-ups and those with a high risk, to find out if the treatment helps both groups.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This early trial tests whether inhaled nitric oxide changes how well your lungs exchange gases during exercise in people with COPD, and compares results with healthy volunteers. It may help researchers understand lung blood-flow and breathing differences that could affect symptoms and exercise tolerance.
This trial tests if breathing in a medicine called nitroglycerin can help people with severe COPD and high blood pressure in their lungs. It aims to see if this treatment improves breathing during a COPD exacerbation.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.